Cumberland Pharmaceuticals (CPIX) Current Deferred Tax Assets (2010 - 2015)
Cumberland Pharmaceuticals (CPIX) reported Current Deferred Tax Assets of $2.5 million for Q4 2015, down 30.74% on a YoY basis from $3.7 million in Q4 2014, and down 30.74% sequentially from $3.7 million in Q4 2014.
Cumberland Pharmaceuticals (CPIX) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 6 years of Current Deferred Tax Assets data on file, last reported at $2.5 million in Q4 2015.
- For the quarter ending Q4 2015, Current Deferred Tax Assets fell 30.74% year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2015 stood at $2.5 million (down 30.74% YoY), and the FY2015 full-year result was $2.5 million, down 30.74% from the prior year.
- Current Deferred Tax Assets retreated to $2.5 million in Q4 2015, from $3.7 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $3.7 million in Q4 2014 to a low of $2.2 million in Q4 2011.
- A 5-year average of $2.7 million and a median of $2.5 million in 2015 frame the typical range for Current Deferred Tax Assets.
- Across the five-year window, Current Deferred Tax Assets soared 127.21% in 2011 and tumbled 30.74% in 2015, its largest moves.
- Tracing CPIX's Current Deferred Tax Assets over 5 years: stood at $2.2 million in 2011, then increased by 2.98% to $2.3 million in 2012, then increased by 18.4% to $2.7 million in 2013, then jumped by 34.65% to $3.7 million in 2014, then plunged by 30.74% to $2.5 million in 2015.
- Business Quant data shows CPIX's Current Deferred Tax Assets at $2.5 million in Q4 2015, $3.7 million in Q4 2014, and $2.7 million in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 2.53 Mn |
| Dec 31, 2015 | 2.53 Mn |
| Dec 31, 2014 | 3.65 Mn |
| Dec 31, 2014 | 3.65 Mn |
| Dec 31, 2013 | 2.71 Mn |
| Dec 31, 2013 | 2.71 Mn |
| Dec 31, 2012 | 2.29 Mn |
| Dec 31, 2012 | 2.29 Mn |
| Dec 31, 2011 | 2.22 Mn |
| Dec 31, 2011 | 2.22 Mn |
| Dec 31, 2010 | 978,771.00 |
| Dec 31, 2010 | 978,771.00 |